XM does not provide services to residents of the United States of America.

FX options wrap - Fed USD boost supports volatility risk premium



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-FX options wrap - Fed USD boost supports volatility risk premium</title></head><body>

A more hawkish than expected U.S. Federal Reserve policy decision surprised the market. Subsequent USD gains exceeded the low overnight expiry implied volatility break-evens in EUR/USD and lifted broader market implied volatility late Wednesday. However, USD/JPY spot and implied volatility bulls had to wait for the Bank of Japan rate hold early Thursday.

EUR/USD benchmark 1-month expiry implied volatility jumped from 7.5 to 7.9 and 1-year extended new long term highs to 7.9. Long Vega trades have reaped huge rewards since the U.S. election, with 1-year implied volatility up from 6.5.

Three billion euros of 1.0400 strike expiries helped to contain EUR/USD on Thursday and there are billions more in the vicinity for Friday's expiry. Barriers and triggers below 1.0300 with expiries through Q1 2025, will strengthen support.

Post BOJ USD/JPY gains saw 1-month recover from post US election lows at 9.75 to 10.15, while 1-year gained from 10.1 to 10.35. Risk reversals trimmed a little more downside over upside strike premium as focus shifts to 160.00.

The Dovish Bank of England hold justified the higher overnight break-evens amid the subsequent GBP slide. Three-month and 1-year expiry implied volatility extended recent gains, while 1-month held steady in the low 7's.

AUD/USD 1-month expiry implied volatility tested the top of its post U.S. election 9.0-10.0 range post Fed, while 3-month and 1-year reached new highs since August.

For more click on FXBUZ


USD/JPY FX option implied volatility https://tmsnrt.rs/3Dl7IRz

EUR/USD FX option strike expiries Dec 19-23 https://tmsnrt.rs/4gknjzG

EUR/USD FXO 1-3-12-month expiry implied volatility https://tmsnrt.rs/4fpzdqr

(Richard Pace is a Reuters market analyst. The views expressed are his own)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.